# Omalizumab for Plant-Food Allergy Due to Sensitization to LTP or Profilin

> **NCT07073404** · — · NOT_YET_RECRUITING · sponsor: **Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud** · enrollment: 37 (estimated)

## Conditions studied

- Food Allergies

## Interventions

- **DRUG:** Omalizumab Injection

## Key facts

- **NCT ID:** NCT07073404
- **Lead sponsor:** Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07073404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07073404, "Omalizumab for Plant-Food Allergy Due to Sensitization to LTP or Profilin". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07073404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*